Filing metadata

Accession number
0000899243-22-012167
Form type
Form 3
Filer
AN2 Therapeutics, Inc.
CIK
CIK 1880438
Filed
Mar 24, 2022
Reporting period
Mar 24, 2022
Description
Initial ownership

Explore SEC Filings Hub